{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:39:48Z","timestamp":1784824788369,"version":"3.55.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Inova Heart and Vascular Institute"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK040561"],"award-info":[{"award-number":["P30 DK040561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nutrition Obesity Research Center at Harvard","award":["M01RR01066"],"award-info":[{"award-number":["M01RR01066"]}]},{"name":"Nutrition Obesity Research Center at Harvard","award":["1UL1RR025758"],"award-info":[{"award-number":["1UL1RR025758"]}]},{"name":"Nutrition Obesity Research Center at Harvard","award":["8UL1TR000170"],"award-info":[{"award-number":["8UL1TR000170"]}]},{"DOI":"10.13039\/100007299","name":"Harvard Clinical and Translational Science Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5KL2TR001100-05"],"award-info":[{"award-number":["5KL2TR001100-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>People with human immunodeficiency virus (PWH) demonstrate increased atherosclerotic cardiovascular disease (ASCVD). Statins are being studied to prevent ASCVD in human immunodeficiency virus (HIV), but little is known regarding the effects of statins on a broad range of inflammatory and cardiovascular proteins in this population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used a highly specific discovery proteomic approach (Protein Extension Assay), to determine statin effects on over 350 plasma proteins in relevant ASCVD pathways among HIV and non-HIV groups. Responses to pitavastatin calcium were assessed in 89 PWH in the INTREPID trial and 46 non-HIV participants with features of central adiposity and insulin resistance. History of cardiovascular disease was exclusionary for both studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among participants with HIV, PCOLCE (enzymatic cleavage of type I procollagen) significantly increased after pitavastatin therapy and PLA2G7 (systemic marker of arterial inflammation) decreased. Among participants without HIV, integrin subunit alpha M (integrin adhesive function) and defensin alpha-1 (neutrophil function) increased after pitavastatin therapy and PLA2G7 decreased. At baseline, comparing participants with and without HIV, differentially expressed proteins included proteins involved in platelet and endothelial function and immune activation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Pitavastatin affected proteins important to platelet and endothelial function and immune activation, and effects differed to a degree within PWH and participants without HIV.<\/jats:p><\/jats:sec>","DOI":"10.1093\/infdis\/jiaa196","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T19:09:49Z","timestamp":1587064189000},"page":"929-939","source":"Crossref","is-referenced-by-count":26,"title":["Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach"],"prefix":"10.1093","volume":"222","author":[{"given":"Chris","family":"deFilippi","sequence":"first","affiliation":[{"name":"Inova Heart and Vascular Institute, Falls Church, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Toribio","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Metabolism Unit and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Ping","family":"Wong","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Department of Molecular Biology and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Sadreyev","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Department of Molecular Biology and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Grundberg","sequence":"additional","affiliation":[{"name":"Olink Proteomics, Watertown, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen V","family":"Fitch","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Metabolism Unit and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markella V","family":"Zanni","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Metabolism Unit and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Lo","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Metabolism Unit and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A","family":"Sponseller","sequence":"additional","affiliation":[{"name":"KOWA Pharmaceuticals America, Inc., Montgomery, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmett","family":"Sprecher","sequence":"additional","affiliation":[{"name":"Olink Proteomics, Watertown, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Rashidi","sequence":"additional","affiliation":[{"name":"Olink Proteomics, Watertown, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie A","family":"Thompson","sequence":"additional","affiliation":[{"name":"AIDS Research Consortium of Atlanta, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Cagliero","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Metabolism Unit and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A","family":"Aberg","sequence":"additional","affiliation":[{"name":"Mount Sinai Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie R","family":"Braun","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Metabolism Unit and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takara L","family":"Stanley","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Metabolism Unit and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Lee","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Biostatistics Center and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K","family":"Grinspoon","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Metabolism Unit and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"2020081708170870300_CIT0001","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2020081708170870300_CIT0002","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.jacc.2016.10.031","article-title":"Proteomics research in cardiovascular medicine and biomarker discovery","volume":"68","author":"Lam","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2020081708170870300_CIT0003","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/S2352-3018(17)30075-9","article-title":"Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial","volume":"4","author":"Aberg","year":"2017","journal-title":"Lancet HIV"},{"key":"2020081708170870300_CIT0004","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ebiom.2018.08.039","article-title":"Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: analysis of data from INTREPID, a randomized controlled trial","volume":"35","author":"Toribio","year":"2018","journal-title":"EBioMedicine"},{"key":"2020081708170870300_CIT0005","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1210\/jc.2018-01446","article-title":"Effects of pitavastatin on insulin sensitivity and liver fat: a randomized clinical trial","volume":"103","author":"Braun","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2020081708170870300_CIT0006","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40262-013-0075-4","article-title":"Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors","volume":"52","author":"Chauvin","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"2020081708170870300_CIT0007","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/QAD.0000000000001427","article-title":"Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV","volume":"31","author":"Toribio","year":"2017","journal-title":"AIDS"},{"key":"2020081708170870300_CIT0008","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0000000000001762","article-title":"Novel mediators of statin effects on plaque in HIV: a proteomics approach","volume":"32","author":"deFilippi","year":"2018","journal-title":"AIDS"},{"key":"2020081708170870300_CIT0009","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B"},{"key":"2020081708170870300_CIT0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2096","article-title":"The role of junctional adhesion molecules in vascular inflammation","volume":"7","author":"Weber","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2020081708170870300_CIT0011","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2010-01-261206","article-title":"Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis","volume":"116","author":"Lievens","year":"2010","journal-title":"Blood"},{"key":"2020081708170870300_CIT0012","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1073\/pnas.97.13.7464","article-title":"Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype","volume":"97","author":"Lutgens","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020081708170870300_CIT0013","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/15271","article-title":"Requirement for CD154 in the progression of atherosclerosis","volume":"5","author":"Lutgens","year":"1999","journal-title":"Nat Med"},{"key":"2020081708170870300_CIT0014","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tcm.2007.02.004","article-title":"CD40 and its ligand in atherosclerosis","volume":"17","author":"Lutgens","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"2020081708170870300_CIT0015","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1161\/01.CIR.0000074043.46437.44","article-title":"Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones","volume":"107","author":"Varo","year":"2003","journal-title":"Circulation"},{"key":"2020081708170870300_CIT0016","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/01.ATV.0000182904.08513.60","article-title":"Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study","volume":"25","author":"de Lemos","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020081708170870300_CIT0017","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1086\/605695","article-title":"HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection","volume":"200","author":"Santosuosso","year":"2009","journal-title":"J Infect Dis"},{"key":"2020081708170870300_CIT0018","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.4049\/jimmunol.172.4.2678","article-title":"CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription","volume":"172","author":"Zhang","year":"2004","journal-title":"J Immunol"},{"key":"2020081708170870300_CIT0019","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/geno.1998.5663","article-title":"Structural organization and expression patterns of the human and mouse genes for the type I procollagen COOH-terminal proteinase enhancer protein","volume":"55","author":"Scott","year":"1999","journal-title":"Genomics"},{"key":"2020081708170870300_CIT0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0945-053X(98)90013-0","article-title":"Procollagen N-proteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling","volume":"16","author":"Prockop","year":"1998","journal-title":"Matrix Biol"},{"key":"2020081708170870300_CIT0021","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/QAD.0b013e32835eca9b","article-title":"Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men","volume":"27","author":"Zanni","year":"2013","journal-title":"AIDS"},{"key":"2020081708170870300_CIT0022","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1586\/erc.10.18","article-title":"Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker","volume":"8","author":"Toth","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2020081708170870300_CIT0023","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1074\/jbc.273.7.4012","article-title":"Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation","volume":"273","author":"Cao","year":"1998","journal-title":"J Biol Chem"},{"key":"2020081708170870300_CIT0024","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/QAD.0000000000000946","article-title":"Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV","volume":"30","author":"Nou","year":"2016","journal-title":"AIDS"},{"key":"2020081708170870300_CIT0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2012.6698","article-title":"Arterial inflammation in patients with HIV","volume":"308","author":"Subramanian","year":"2012","journal-title":"JAMA"},{"key":"2020081708170870300_CIT0026","doi-asserted-by":"crossref","first-page":"e0181533","DOI":"10.1371\/journal.pone.0181533","article-title":"The role of the tissue factor and its inhibitor in the development of subclinical atherosclerosis in people living with HIV","volume":"12","author":"Barska","year":"2017","journal-title":"PLoS One"},{"key":"2020081708170870300_CIT0027","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaa196\/33226959\/jiaa196.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/6\/929\/33656522\/jiaa196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/6\/929\/33656522\/jiaa196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T05:11:18Z","timestamp":1722748278000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/222\/6\/929\/5822753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,4,20]]},"published-print":{"date-parts":[[2020,8,17]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa196","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,15]]},"published":{"date-parts":[[2020,4,20]]}}}